Medicover Financial Statements From 2010 to 2024
| 5M0B Stock | EUR 15.06 0.08 0.53% |
Check Medicover financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicover's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medicover financial statements analysis is a perfect complement when working with Medicover Valuation or Volatility modules.
Medicover |
Medicover AB Company Current Valuation Analysis
Medicover's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medicover Current Valuation | 2.94 B |
Most of Medicover's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicover AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medicover AB has a Current Valuation of 2.94 B. This is 79.54% lower than that of the Healthcare sector and 95.09% lower than that of the Health Care Plans industry. The current valuation for all Germany stocks is 82.32% higher than that of the company.
Medicover AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicover's current stock value. Our valuation model uses many indicators to compare Medicover value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicover competition to find correlations between indicators driving Medicover's intrinsic value. More Info.Medicover AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.92 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicover AB is roughly 1.09 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicover's earnings, one of the primary drivers of an investment's value.About Medicover Financial Statements
Medicover stakeholders use historical fundamental indicators, such as Medicover's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medicover investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medicover's assets and liabilities are reflected in the revenues and expenses on Medicover's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medicover AB. Please read more on our technical analysis and fundamental analysis pages.
Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. MEDICOVER operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 20970 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicover Stock
Medicover financial ratios help investors to determine whether Medicover Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicover with respect to the benefits of owning Medicover security.